• CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin
  • CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin
  • CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin
  • CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin
  • CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin
  • CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin

CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin

Varieties: Parasite Disease Prevention Medicine
Component: Animal
Type: The First Class
Pharmacodynamic Influential Factors: Animal Species
Storage Method: Prevent High or LowTemperature
Veterinary Reg. No.: 09853
Samples:
US$ 50/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory

Basic Info.

Model NO.
Moxifloxacin
Product
Marbofloxacin
CAS
115550-35-1
Mf
C17h19fn4o4
Transport Package
Drum
Specification
99%
Trademark
HS
Origin
China
HS Code
2904201000
Production Capacity
100000

Product Description

CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin
Product Information
Other Name marbofloxacin
Assay 99%
Appearance White crystalline powder
Package 1kg/carton; 25kg/drum
Payment Alipay; Western Union; TT
Shipment DHL; FedEx, EMS; Air; Sea
Standard USP/EP/CP/BP
Storage Sealed in dark and dry place
Shelf Life 3 Years
What's marbofloxacin? 

Marbofloxacin is a new type of fluoroquinolone antibacterial. It inhibits the growth of bacteria by inhibiting the DNA transcriptase of bacteria. It has antibacterial effects on Gram-negative bacteria, Gram-positive bacteria and Mycoplasma. Marbofloxacin can be well absorbed through oral and injection administration, with low side effects.

Marbofloxacin is used for the respiratory tract, digestive tract, urinary tract and skin infections of cattle, pigs, dogs and cats caused by sensitive bacteria. It is also effective for bovine and goat mastitis and swine mastitis-metritis-agalactia syndrome.


 
CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin
Application & Function of marbofloxacin

Marbofloxacin is a fluoroquinolone antibacterial drug used to treat deep and superficial skin infections, urinary tract infections in dogs, skin and soft tissue infections in cats, and acute upper respiratory infections.

Used for respiratory tract, digestive tract, urinary tract and skin infections of cattle, pigs, dogs and cats caused by sensitive bacteria. It is also effective for bovine and goat mastitis and swine mastitis-metritis-agalactia syndrome.

Withdrawal period: 6 days for cattle, 1.5 days for milk abandonment period; 2 days for pigs.


Marbofloxacin can be used both orally and topically. It is particularly used for infections of the skin, respiratory system and mammary glands, as well as with urinary tract infections in dogs and cats. For dogs, a dose of approximately 2 mg/kg is used. The duration of treatment is usually at least five days, longer if there is a concurrent fungal or yeast infection.
 Malbofloxacin is a novel fluoroquinolone antibacterial agent that inhibits the growth of bacteria by inhibiting bacterial DNA transcriptase and has antibacterial effects against Gram-negative bacteria, Gram-positive bacteria and mycoplasma. Malborfloxacin is well absorbed by both oral and injectable drugs with low toxic and side effects.
Fluoroquinolones are used to treat deep and superficial skin infections in dogs, urinary tract infections, cat skin and soft tissue infections, and acute upper respiratory tract infections.
It is used for the infection of respiratory tracts, digestive tracts, urinary tracts and skin caused by susceptible bacteria in cattle, pigs, dogs and cats. It is also effective for cattle, sheep mastitis, and swine mastitis-myometitis-agalactia syndrome.

 

1. Dogs and Cats

The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

2. Cattle

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

3. Pigs

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
The advantage to choose HNB Biotech Company: 
Before-Sale Service:
---Any inquiries will be replied within 12 hours.
---Golden Manufactory under ISO/GMP with large stock.
---Dedication to quality,We have strict quality control system. 
---OEM/ODM Available.
---Sample is available for your evaluation & Formulation development.
---Low MOQ: No worry about the big MOQ.
---Fast Delivery: Narmolly grt it within 7-10 days after confirming the order.
---Convenient Payment: Trade Assurance on Alibaba(Visa or Credit card), Western Union or TT 

After-Sale Service:
---International Authorized Third-Party Test For The Products You Demand.
---60 Days Warranty of quality of goods.

What's more:
Looking forward to having a long-term cooperation with us in China !
Welcome to visit our factory ! ! !

CAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin
ANALYTICAL ITEMS SPECIFICATION ANALYTICAL RESULTS
Appearance White Powder Confirms
PH 4.0-6.0 Confirms
Related substances ≤1.0% Confirms
Moisture 3.0~4.0% Confirms
Residue on ignition no more than 0.2% Confirms
Heavy metal no more than 0.001% Confirms
residual solvent Conforms to the requirement Confirms
Assay 98.0%~102.0% 99.5%
Conclusion Confirms to Enterprise Standard
CAS 186826-86-8 Moxifloxacin HCl Hydrochloride MoxifloxacinCAS 186826-86-8 Moxifloxacin HCl Hydrochloride MoxifloxacinCAS 186826-86-8 Moxifloxacin HCl Hydrochloride MoxifloxacinCAS 186826-86-8 Moxifloxacin HCl Hydrochloride MoxifloxacinCAS 186826-86-8 Moxifloxacin HCl Hydrochloride MoxifloxacinCAS 186826-86-8 Moxifloxacin HCl Hydrochloride Moxifloxacin

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory
Registered Capital
10000000 RMB
Plant Area
101~500 square meters